Spruce Biosciences, Inc. (SPRB)
NASDAQ: SPRB · Real-Time Price · USD
46.96
+0.70 (1.51%)
Aug 5, 2026, 1:27 PM EDT - Market open
Spruce Biosciences Market Cap
Spruce Biosciences has a market cap or net worth of $129.25 million as of August 5, 2026. Its market cap has increased by 2,450.38% in one year.
Market Cap
129.25M
Enterprise Value
80.36M
1-Year Change
2,450.38%
Ranking
Category
Stock Price
$46.96
ChartMarket Cap Chart
Since October 9, 2020, Spruce Biosciences's market cap has decreased from $378.48M to $129.25M, a decrease of -65.85%. That is a compound annual growth rate of -16.84%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 5, 2026 | 129.25M | 38.62% |
| Dec 31, 2025 | 93.24M | 437.50% |
| Dec 31, 2024 | 17.35M | -85.46% |
| Dec 29, 2023 | 119.28M | 361.35% |
| Dec 30, 2022 | 25.86M | -75.29% |
| Dec 31, 2021 | 104.65M | -81.46% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Oct 9, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| PepGen | 130.04M |
| Nautilus Biotechnology | 128.53M |
| ProMIS Neurosciences | 126.80M |
| Tiziana Life Sciences | 125.34M |
| Connect Biopharma Holdings | 124.04M |
| Seer, Inc. | 123.16M |
| enGene Therapeutics | 118.57M |
| Anixa Biosciences | 116.02M |